<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01111136</url>
  </required_header>
  <id_info>
    <org_study_id>2010-0052</org_study_id>
    <nct_id>NCT01111136</nct_id>
  </id_info>
  <brief_title>Stress Intervention for Chronic Urticaria</brief_title>
  <official_title>Effect of Psychological Stress Intervention for Patients With Chronic Urticaria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Mississippi Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Mississippi Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stress and chronic urticaria has been linked. The purpose of the study is to evaluate a
      patients chronic urticaria and stress levels before and after he/she goes through six
      sessions designed to help that participant manage his/her stress.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this single-arm, interventional pilot study is to evaluate the effect of
      psychological stress intervention for patients with chronic urticaria, as many of these
      patients report heightened levels of stress before and/or after the onset of the urticaria.
      Participants will meet individually with a University of Mississippi Medical Center
      psychiatry resident for one hour once a week for six consecutive weeks to be educated on
      psychological stress intervention techniques. There is no control group for this pilot study.
      All participants will complete a packet of psychological and dermatological questionnaires
      before the first session with the psychiatry resident and one week after the final session.
      All participants will record daily 1) their urticaria symptoms and 2) the type and number of
      medications taken for his/her chronic hives. If psychological stress intervention proves to
      be effective, then this therapeutic modality would benefit patients with chronic urticaria,
      while avoiding addition and/or continuation of medications that may have significant adverse
      side effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Urticaria Activity Score</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measures the daily level of skin itching and the number of hives as the study progresses.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of stress.</measure>
    <time_frame>7 weeks</time_frame>
    <description>A set of questionnaires done before the first session and after the sixth/final session will be done to compare level of stress.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Chronic Urticaria</condition>
  <arm_group>
    <arm_group_label>stress intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stress intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Stress intervention</intervention_name>
    <description>To evaluate psychological stress, participants will complete the Perceived Stress Scale, Beck Depression Inventory-Fast Screen, Anxiety Sensitivity Index-III, Posttraumatic Stress Diagnostic Scale and the Depression Anxiety Stress Scales; to evaluate cognitive and behavioral aspects of emotional avoidance, participants will complete the Emotional Avoidance Questionnaire as well as the Acceptance and Action Questionnaire, Difficulties in Emotion Regulation Scale, Illness Attitudes Scale and the Five Facet Mindfulness Questionnaire; and to evaluate quality of life in regards to his/her skin condition, participants will complete the Dermatology Life Quality Index questionnaire.</description>
    <arm_group_label>stress intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females age 18-64 years old who have had hives for longer than 6 weeks.

          -  Hives persist despite medical therapy.

          -  Minimum Urticaria Activity Score of 2 (one point from each of the two categories:
             number of hives and severity of pruritus).

        Exclusion Criteria:

          -  Urticaria secondary to vasculitis.

          -  Urticaria as part of an anaphylactic response.

          -  Use of Omalizumab within 3 months preceding enrollment period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John W. Tole, D.O.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Mississippi Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gailen D. Marshall, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Mississippi Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Powell RJ, Du Toit GL, Siddique N, Leech SC, Dixon TA, Clark AT, Mirakian R, Walker SM, Huber PA, Nasser SM; British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy. 2007 May;37(5):631-50.</citation>
    <PMID>17456211</PMID>
  </reference>
  <reference>
    <citation>Sperber J, Shaw J, Bruce S. Psychological components and the role of adjunct interventions in chronic idiopathic urticaria. Psychother Psychosom. 1989;51(3):135-41.</citation>
    <PMID>2636418</PMID>
  </reference>
  <reference>
    <citation>Papadopoulou N, Kalogeromitros D, Staurianeas NG, Tiblalexi D, Theoharides TC. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol. 2005 Nov;125(5):952-5.</citation>
    <PMID>16297195</PMID>
  </reference>
  <reference>
    <citation>Yang HY, Sun CC, Wu YC, Wang JD. Stress, insomnia, and chronic idiopathic urticaria--a case-control study. J Formos Med Assoc. 2005 Apr;104(4):254-63.</citation>
    <PMID>15909063</PMID>
  </reference>
  <reference>
    <citation>Ozkan M, Oflaz SB, Kocaman N, Ozseker F, Gelincik A, Büyüköztürk S, Ozkan S, Colakoğlu B. Psychiatric morbidity and quality of life in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2007 Jul;99(1):29-33.</citation>
    <PMID>17650826</PMID>
  </reference>
  <reference>
    <citation>Silvares MR, Coelho KI, Dalben I, Lastória JC, Abbade LP. Sociodemographic and clinical characteristics, causal factors and evolution of a group of patients with chronic urticaria-angioedema. Sao Paulo Med J. 2007 Sep 6;125(5):281-5.</citation>
    <PMID>18094895</PMID>
  </reference>
  <reference>
    <citation>Berrino AM, Voltolini S, Fiaschi D, Pellegrini S, Bignardi D, Minale P, Troise C, Maura E. Chronic urticaria: importance of a medical-psychological approach. Eur Ann Allergy Clin Immunol. 2006 May;38(5):149-52.</citation>
    <PMID>17058846</PMID>
  </reference>
  <reference>
    <citation>Annesi-Maesano I, Beyer A, Marmouz F, Mathelier-Fusade P, Vervloet D, Bauchau V. Do patients with skin allergies have higher levels of anxiety than patients with allergic respiratory diseases? Results of a large-scale cross-sectional study in a French population. Br J Dermatol. 2006 Jun;154(6):1128-36.</citation>
    <PMID>16704645</PMID>
  </reference>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2010</study_first_submitted>
  <study_first_submitted_qc>April 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2010</study_first_posted>
  <last_update_submitted>November 23, 2010</last_update_submitted>
  <last_update_submitted_qc>November 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>John W. Tole, D.O.</name_title>
    <organization>University of Mississippi Medical Center</organization>
  </responsible_party>
  <keyword>Urticaria</keyword>
  <keyword>Hives</keyword>
  <keyword>Stress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urticaria</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

